Rhode Island Society of Health System Pharmacists
Residents Pearls
Pharmacists and Pharmacy Technicians
2.5 Contact Hours (0.25 CEUs)
April 18, 2019
Wyndham Providence
1850 Post Road, Warwick, RI 02886
(401) 738-4000
Topics:
“Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in frail older adults after myocardial infarction”
Melissa Riester, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island Hospital
“Predictors of hip fracture among frail older adults treated with bisphosphonates”
Mark Sorial, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island Hospital
“Implementation of an Intranasal Ketamine, Midazolam and Fentanyl Policy for Pediatric Patients in the Emergency Department”
David Krok, PharmD, PGY1 Pharmacy Practice Resident, South County Hospital
“Retrospective evaluation of evidence-based major depressive disorder management in a primary care setting”
Lyndsey Garde, PharmD, PGY1 Pharmacy Practice Resident, Coastal Medical
“Management of immunotherapy-mediated adverse events: patient case presentation”
Kerry Baeder, PharmD, PGY1 Pharmacy Practice Resident, South County Hospital
“Impact of novel clinical decision support rules on guiding antibiotic selection for patients with documented penicillin allergies in a community teaching hospital”
Ally Gomez, PharmD, PGY1 Pharmacy Practice Resident, Kent Hospital
“Initiatives used to Reduce the use of diphenhydramine in Geriatric Patients in a Community Teaching Hospital”
Jordan O’Leary, PharmD, PGY1 Pharmacy Practice Resident, Kent Hospital
“Adherence and cost outcomes associated with multi-blister medication packaging for Veterans with mental health intensive case management (MHICM) at Providence Veterans Affairs Medical Center (PVAMC)”
Ashley Chace, PharmD, PGY1 Pharmacy Practice Resident, Providence VA Medical Center
“Evaluation of empagliflozin for the treatment of type 2 diabetes mellitus at the Providence Veterans Affairs Medical Center”
Kenzi Lopes-Pimental, PharmD, PGY1 Pharmacy Practice Resident, Providence VA Medical Center
“Clinical Insights: Hepatitis C and Substance Use Disorders”
Giuseppina Sclafani, PharmD, PGY1 Pharmacy Practice Resident, Providence VA Medical Center
Program Agenda:
5:00 PM Registration
5:15 PM Dinner Buffet Begins
5:45 PM Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in frail older adults after myocardial infarction
6:00 PM Predictors of hip fracture among frail older adults treated with bisphosphonates
6:15 PM Implementation of an Intranasal Ketamine, Midazolam and Fentanyl Policy for Pediatric Patients in the Emergency Department
6:30 PM Retrospective evaluation of evidence-based major depressive disorder management in a primary care setting
6:45 PM Management of immunotherapy-mediated adverse events: patient case presentation
7:00 PM Coffee Break
7:15 PM Impact of novel clinical decision support rules on guiding antibiotic selection for patients with documented penicillin allergies in a community teaching hospital
7:30 PM Initiatives used to Reduce the use of diphenhydramine in Geriatric Patients in a Community Teaching Hospital
7:45 PM Adherence and cost outcomes associated with multi-blister medication packaging for Veterans with mental health intensive case management (MHICM) at Providence Veterans Affairs Medical Center (PVAMC)
8:00 PM Evaluation of empagliflozin for the treatment of type 2 diabetes mellitus at the Providence Veterans Affairs Medical Center
8:15 PM Clinical Insights: Hepatitis C and Substance Use Disorders
Members: $25.00
Non-Members: $50.00
Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.
Learning Objectives
Upon completion of this learning activity, pharmacist participants will be able to:
“Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in frail older adults after myocardial infarction”
1. Explain how the results of a retrospective national cohort study could affect future prescribing practices in frail, older adults after acute myocardial infarction
“Predictors of hip fracture among frail older adults treated with bisphosphonates”
1. Describe how the results of this study will affect patient monitoring during bisphosphonate therapy
“Implementation of an Intranasal Ketamine, Midazolam and Fentanyl Policy for Pediatric Patients in the Emergency Department”
1. Outline the steps and processes of implementing a nursing/physician driven procedure.
2. Review the process that aides providers in choosing the most appropriate medication.
“Retrospective evaluation of evidence-based major depressive disorder management in a primary care setting”
1. Discuss how to identify patients struggling with depression based on their symptom presentation and/or the results of screening
2. Explain the validity of the Patient Health Questionnaire 9 in guiding treatment decisions
“Management of immunotherapy-mediated adverse events: patient case presentation”
1. Describe the manifestation of adverse effects associated with immunotherapy drugs
2. Explain how to navigate the National Comprehensive Cancer Network and American Society of Clinical Oncology Guidelines to determine appropriate recommendations to treat patients presenting with immunotherapy mediated adverse drug reactions.
“Impact of novel clinical decision support rules on guiding antibiotic selection for patients with documented penicillin allergies in a community teaching hospital”
1. Discuss the impact of documented penicillin allergy in clinical practice
2. Explain the impact of clinical decision support and expanded penicillin allergy history on prescribing practices of antimicrobial therapy in patients with documented penicillin allergies
“Initiatives used to Reduce the use of diphenhydramine in Geriatric Patients in a Community Teaching Hospital”
1. Explain how diphenhydramine usage restriction is a beneficial patient safety tool
2. List Kent Hospital approved indications for diphenhydramine
“Adherence and cost outcomes associated with multi-blister medication packaging for Veterans with mental health intensive case management (MHICM) at Providence Veterans Affairs Medical Center (PVAMC)”
1. Explain consequences of medication non-adherence
2. Determine patient eligibility for Mental Health Intensive Case Management (MHICM)
“Evaluation of empagliflozin for the treatment of type 2 diabetes mellitus at the Providence Veterans Affairs Medical Center”
1. Describe SGLT-2 inhibitors mechanism of action in type 2 diabetes
2. List the potential glycemic and non-glycemic benefits of using SGLT-2 inhibitors
“Clinical Insights: Hepatitis C and Substance Use Disorders”
1. Review risk factors and prevalence of hepatitis C virus (HCV) among Veterans with comorbid substance use disorder (SUD)
2. Explain the Veterans Affairs’ best practices and efforts to reduce the burden of HCV infection
Upon completion of this learning activity, technician participants will be able to:
“Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in frail older adults after myocardial infarction”
1. List renin-angiotensin-aldosterone system inhibitor classes used in older adults after acute myocardial infarction
“Predictors of hip fracture among frail older adults treated with bisphosphonates”
1. List 2 pharmacologic options for fracture prevention
“Implementation of an Intranasal Ketamine, Midazolam and Fentanyl Policy for Pediatric Patients in the Emergency Department”
1. Describe why Ketamine, Midazolam, and Fentanyl would be used in the pediatric population and how they are administered.
2. Review the monitoring and side effects associated with the use of Ketamine, Midazolam, and Fentanyl on the pediatric population
“Retrospective evaluation of evidence-based major depressive disorder management in a primary care setting”
1. List symptoms of depression.
“Management of immunotherapy-mediated adverse events: patient case presentation”
1. Identify side effects of receiving immunotherapy drugs
2. Recognize the organizations associated with guidelines for proper management of these side effects
“Impact of novel clinical decision support rules on guiding antibiotic selection for patients with documented penicillin allergies in a community teaching hospital”
1. Explain the impact of documented penicillin allergy in clinical practice
“Initiatives used to Reduce the use of diphenhydramine in Geriatric Patients in a Community Teaching Hospital”
1. Define delirium and medication induced delirium
“Adherence and cost outcomes associated with multi-blister medication packaging for Veterans with mental health intensive case management (MHICM) at Providence Veterans Affairs Medical Center (PVAMC)”
1. Review the multi-blister medication packaging program at PVAMC
“Evaluation of empagliflozin for the treatment of type 2 diabetes mellitus at the Providence Veterans Affairs Medical Center”
1. List the common adverse effects of empagliflozin
“Clinical Insights: Hepatitis C and Substance Use Disorders”
1. List risk factors for HCV in the Veteran population
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists and pharmacy technicians will receive 2.5 contact hours (0.25 ceus) for the educational activity. ACPE UAN: 0060-9999-19-019-L01-P (Pharmacists) ACPE UAN: 0060-9999-19-019-L01-T (Technicians). Activity release date: April 18, 2019.
REQUIREMENTS FOR CE CREDIT
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
Financial support provided by the Rhode Island Society of Health-System Pharmacists
